NICE LTD - SPON ADR (NICE) Stock Fundamental Analysis
USA - NASDAQ:NICE - US6536561086 - ADR
131.46 USD
-0.54 (-0.41%)
131.46 USD
0 (0%)
NICE gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 282 industry peers in the Software industry. NICE has an excellent profitability rating, but there are some minor concerns on its financial health. NICE is valued quite cheap, while showing a decent growth score. This is a good combination! With these ratings, NICE could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
In the past year NICE was profitable.
NICE had a positive operating cash flow in the past year.
NICE had positive earnings in each of the past 5 years.
Each year in the past 5 years NICE had a positive operating cash flow.
1.2 Ratios
The Return On Assets of NICE (10.06%) is better than 85.46% of its industry peers.
NICE's Return On Equity of 14.31% is amongst the best of the industry. NICE outperforms 81.91% of its industry peers.
NICE has a Return On Invested Capital of 11.37%. This is amongst the best in the industry. NICE outperforms 87.59% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for NICE is below the industry average of 11.88%.
The 3 year average ROIC (8.49%) for NICE is below the current ROIC(11.37%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.06% | ||
| ROE | 14.31% | ||
| ROIC | 11.37% |
ROA(3y)6.78%
ROA(5y)5.84%
ROE(3y)10.34%
ROE(5y)9.15%
ROIC(3y)8.49%
ROIC(5y)7.35%
1.3 Margins
NICE has a better Profit Margin (18.81%) than 82.98% of its industry peers.
In the last couple of years the Profit Margin of NICE has grown nicely.
NICE's Operating Margin of 21.39% is amongst the best of the industry. NICE outperforms 87.59% of its industry peers.
In the last couple of years the Operating Margin of NICE has grown nicely.
NICE has a Gross Margin of 67.03%. This is comparable to the rest of the industry: NICE outperforms 46.45% of its industry peers.
NICE's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.39% | ||
| PM (TTM) | 18.81% | ||
| GM | 67.03% |
OM growth 3Y13.23%
OM growth 5Y5.7%
PM growth 3Y15.65%
PM growth 5Y6.35%
GM growth 3Y-0.37%
GM growth 5Y0.16%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NICE is still creating some value.
The number of shares outstanding for NICE has been increased compared to 1 year ago.
NICE has more shares outstanding than it did 5 years ago.
NICE has a better debt/assets ratio than last year.
2.2 Solvency
NICE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.7 | ||
| Altman-Z | N/A |
ROIC/WACC1.27
WACC8.98%
2.3 Liquidity
NICE has a Current Ratio of 1.83. This is a normal value and indicates that NICE is financially healthy and should not expect problems in meeting its short term obligations.
NICE's Current ratio of 1.83 is in line compared to the rest of the industry. NICE outperforms 58.51% of its industry peers.
A Quick Ratio of 1.83 indicates that NICE should not have too much problems paying its short term obligations.
The Quick ratio of NICE (1.83) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.83 | ||
| Quick Ratio | 1.83 |
3. Growth
3.1 Past
NICE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.59%, which is quite good.
The Earnings Per Share has been growing by 15.93% on average over the past years. This is quite good.
Looking at the last year, NICE shows a quite strong growth in Revenue. The Revenue has grown by 11.39% in the last year.
NICE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.69% yearly.
EPS 1Y (TTM)19.59%
EPS 3Y19.48%
EPS 5Y15.93%
EPS Q2Q%14.02%
Revenue 1Y (TTM)11.39%
Revenue growth 3Y12.5%
Revenue growth 5Y11.69%
Sales Q2Q%9.38%
3.2 Future
The Earnings Per Share is expected to grow by 12.40% on average over the next years. This is quite good.
Based on estimates for the next years, NICE will show a quite strong growth in Revenue. The Revenue will grow by 8.30% on average per year.
EPS Next Y14.22%
EPS Next 2Y11.8%
EPS Next 3Y12.4%
EPS Next 5YN/A
Revenue Next Year7.25%
Revenue Next 2Y7.11%
Revenue Next 3Y8.3%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 10.90, the valuation of NICE can be described as reasonable.
Based on the Price/Earnings ratio, NICE is valued cheaply inside the industry as 89.01% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.50. NICE is valued rather cheaply when compared to this.
NICE is valuated reasonably with a Price/Forward Earnings ratio of 9.24.
Based on the Price/Forward Earnings ratio, NICE is valued cheaply inside the industry as 92.55% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.99. NICE is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.9 | ||
| Fwd PE | 9.24 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NICE is valued cheaply inside the industry as 93.97% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NICE indicates a rather cheap valuation: NICE is cheaper than 91.84% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.3 | ||
| EV/EBITDA | 7.34 |
4.3 Compensation for Growth
NICE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NICE has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as NICE's earnings are expected to grow with 12.40% in the coming years.
PEG (NY)0.77
PEG (5Y)0.68
EPS Next 2Y11.8%
EPS Next 3Y12.4%
5. Dividend
5.1 Amount
No dividends for NICE!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
131.46
-0.54 (-0.41%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners12.48%
Inst Owner Change-0.01%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.12B
Analysts81.33
Price Target189.1 (43.85%)
Short Float %3.03%
Short Ratio2.67
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.29%
Min EPS beat(2)-1.41%
Max EPS beat(2)-1.17%
EPS beat(4)1
Avg EPS beat(4)0.63%
Min EPS beat(4)-1.41%
Max EPS beat(4)5.16%
EPS beat(8)5
Avg EPS beat(8)1.44%
EPS beat(12)9
Avg EPS beat(12)1.55%
EPS beat(16)12
Avg EPS beat(16)1.75%
Revenue beat(2)0
Avg Revenue beat(2)-1.05%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-0.14%
Revenue beat(4)0
Avg Revenue beat(4)-1.12%
Min Revenue beat(4)-1.97%
Max Revenue beat(4)-0.14%
Revenue beat(8)0
Avg Revenue beat(8)-1.21%
Revenue beat(12)0
Avg Revenue beat(12)-1.25%
Revenue beat(16)3
Avg Revenue beat(16)-0.49%
PT rev (1m)-5.52%
PT rev (3m)-8.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.6%
EPS NY rev (1m)0.07%
EPS NY rev (3m)1.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.2%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.9 | ||
| Fwd PE | 9.24 | ||
| P/S | 2.86 | ||
| P/FCF | 12.3 | ||
| P/OCF | 10.75 | ||
| P/B | 2.18 | ||
| P/tB | 4.85 | ||
| EV/EBITDA | 7.34 |
EPS(TTM)12.06
EY9.17%
EPS(NY)14.23
Fwd EY10.82%
FCF(TTM)10.69
FCFY8.13%
OCF(TTM)12.23
OCFY9.3%
SpS45.97
BVpS60.43
TBVpS27.1
PEG (NY)0.77
PEG (5Y)0.68
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.06% | ||
| ROE | 14.31% | ||
| ROCE | 15.46% | ||
| ROIC | 11.37% | ||
| ROICexc | 19.46% | ||
| ROICexgc | 188.31% | ||
| OM | 21.39% | ||
| PM (TTM) | 18.81% | ||
| GM | 67.03% | ||
| FCFM | 23.26% |
ROA(3y)6.78%
ROA(5y)5.84%
ROE(3y)10.34%
ROE(5y)9.15%
ROIC(3y)8.49%
ROIC(5y)7.35%
ROICexc(3y)14.21%
ROICexc(5y)12.54%
ROICexgc(3y)163.28%
ROICexgc(5y)N/A
ROCE(3y)11.55%
ROCE(5y)10%
ROICexcg growth 3Y25.64%
ROICexcg growth 5Y53.44%
ROICexc growth 3Y23.73%
ROICexc growth 5Y18.38%
OM growth 3Y13.23%
OM growth 5Y5.7%
PM growth 3Y15.65%
PM growth 5Y6.35%
GM growth 3Y-0.37%
GM growth 5Y0.16%
F-Score7
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.7 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 49.93% | ||
| Cap/Sales | 3.34% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 94.72% | ||
| Profit Quality | 123.61% | ||
| Current Ratio | 1.83 | ||
| Quick Ratio | 1.83 | ||
| Altman-Z | N/A |
F-Score7
WACC8.98%
ROIC/WACC1.27
Cap/Depr(3y)48.45%
Cap/Depr(5y)43.32%
Cap/Sales(3y)3.65%
Cap/Sales(5y)3.66%
Profit Quality(3y)152.88%
Profit Quality(5y)173.68%
High Growth Momentum
Growth
EPS 1Y (TTM)19.59%
EPS 3Y19.48%
EPS 5Y15.93%
EPS Q2Q%14.02%
EPS Next Y14.22%
EPS Next 2Y11.8%
EPS Next 3Y12.4%
EPS Next 5YN/A
Revenue 1Y (TTM)11.39%
Revenue growth 3Y12.5%
Revenue growth 5Y11.69%
Sales Q2Q%9.38%
Revenue Next Year7.25%
Revenue Next 2Y7.11%
Revenue Next 3Y8.3%
Revenue Next 5YN/A
EBIT growth 1Y21.29%
EBIT growth 3Y27.38%
EBIT growth 5Y18.06%
EBIT Next Year21.54%
EBIT Next 3Y9.22%
EBIT Next 5YN/A
FCF growth 1Y49.42%
FCF growth 3Y22.92%
FCF growth 5Y18.61%
OCF growth 1Y42.08%
OCF growth 3Y21.71%
OCF growth 5Y17.35%